Medication
Dextrose Injection Usp
DIN 00037915 · Icu Medical Canada Inc Likely a generic
What it is
- Active ingredients
- Dextrose — 50 mg
- Form and route
- Solution · Intravenous
- Schedule
- ETHICAL
- Authorised since
- 1978-12-31
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.
Products with the same active ingredient
Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.
Watch this medication
Ontario Drug Benefit coverage
As of 31 July 2026This medication is not listed on the Ontario Drug Benefit formulary.
Not on the formulary is not the same as not covered. Private and workplace insurance, federal programs such as Non-Insured Health Benefits and Veterans Affairs, and every other province’s public plan are all outside what this page shows — Ontario is the only province RxMonitor holds coverage data for. Ontario may also fund a product that is not on the formulary through the Exceptional Access Program.
Source: Ontario Ministry of Health — ODB Formulary. Data current as of 2026-07-28. Ontario only. Formulary edition 4342, effective 31 July 2026.
Reported side effects
RxMonitor does not show reported side effects.
Health Canada collects voluntary reports of suspected side effects in the Canada Vigilance database. RxMonitor does not summarise them, because a count of reports is not a rate and the most-reported term for a medication is often the condition it is prescribed for — for a reliever inhaler, the most reported term is asthma. Nothing here should be read as a list of this medication’s side effects, or as evidence that it has few. The product monograph and a pharmacist are the sources for that.
How it is classified
- Anatomical main group
- Blood and blood-forming organs
- ATC code
- B05BA03
The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of B05BA03, see the WHO ATC/DDD Index.
Recalls and safety alerts
As of 12 August 2026Possible matches
These notices name a product name that more than one company sells. They may or may not concern this manufacturer’s product — Health Canada’s data does not say. They are not recalls of this product.
Dextrose Injection USP (2018-06-01)
Possible match. This notice names “DEXTROSE INJECTION USP”, and 2 authorised products from 2 companies are sold under that name. The notice does not say which of them is affected.
This list may be incomplete. Health Canada’s recalls data carries no DIN, so notices are matched on wording alone. Search Health Canada recalls for Dextrose Injection Usp → How RxMonitor matches recalls, and how often it fails
Source: Health Canada — Recalls and Safety Alerts. Data current as of 2026-08-12. Matched on product name, not on DIN — the feed carries none.